By Bhanvi Satija and Sabrina Valle LONDON, June 11 (Reuters) – GSK's record $10.6 billion deal for U.S. company Nuvalent will accelerate the British drugmaker's rebuild of its cancer drug business as
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Japanese companies compensate users as cyberattacks buffet economy
By Kentaro Okasaka and Sam Nussey TOKYO, Oct 26 (Reuters) - Japanese companies are moving…
Here's why Holland Taylor refused to renew her 'Two and a Half Men' contract
Washington [US], October 26 (ANI): Veteran actress Holland Taylor has opened up about her departure…
All Ability National Divyang Cricket Tournament 2026 announced
All Ability National Divyang Cricket Tournament 2026 announced Mumbai (Maharashtra) [India], October 26: In a…
